The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations

Peer Review reports

Original Submission
8 Jun 2018	Submitted	Original manuscript
12 Oct 2018	Reviewed	Reviewer Report - Antoinette Wozniak
13 Oct 2018	Reviewed	Reviewer Report - Kadoaki Ohashi
16 Oct 2018	Reviewed	Reviewer Report - Chong-Rui Xu
30 Oct 2018	Author responded	Author comments - Akihiro Yoshimura
Resubmission - Version 2
30 Oct 2018	Submitted	Manuscript version 2
1 Nov 2018	Reviewed	Reviewer Report - Antoinette Wozniak
6 Nov 2018	Reviewed	Reviewer Report - Kadoaki Ohashi
20 Nov 2018	Reviewed	Reviewer Report - Chong-Rui Xu
26 Nov 2018	Author responded	Author comments - Akihiro Yoshimura
Resubmission - Version 3
26 Nov 2018	Submitted	Manuscript version 3
Publishing
29 Nov 2018	Editorially accepted
11 Dec 2018	Article published	10.1186/s12885-018-5153-4

Back to article page